RTT Press Release
|02/13/2017 - 13:52||
NIH-funded Study of Brain Training Makes TIME List of Top Scientific Discoveries of the Year
SAN FRANCISCO, Feb. 13, 2017 – TIME Magazine has selected the impact on dementia of a brain training exercise – developed and tested with funding from the National Institutes of Health (NIH) – as one of the 100 New Scientific Discoveries of 2016. That exercise is commercially available only in the BrainHQ brain training platform.
|02/13/2017 - 13:08||
New hope for treating heart failure
Promising drug by UAlberta researchers could save millions of lives.
|University of A...|
|02/13/2017 - 12:07||
Twelve Current And Former Tsa And Airport Employees Indicted For Smuggling Approximatley 20 Tons Of Cocaine
SAN JUAN, Puerto Rico – On February 8, 2017, a federal grand jury in the District of Puerto Rico returned a superseding indictment against twelve defendants charged with conspiracy to possess with intent to distribute cocaine, announced Rosa Emilia Rodríguez-Vélez, United States Attorney for the District of Puerto Rico.
|02/13/2017 - 09:49||
Emerging adults may be mixing drug, alcohol, firearms, study finds
While drugs, alcohol and firearms do not mix well, new research finds that among some young adults the three may often go together.
|02/13/2017 - 07:22||
The real-life Notebook? Husband and wife still in love after 50 years despite dementia pulling them apart
A husband and wife with dementia are still head over heels in love after 50 years, despite not always being able to remember who each other are.
|02/13/2017 - 05:21||
Study in the American Journal of Obstetrics & Gynecology finds Glucose Supplementation Significantly Reduces Length of Induced Labor in Childbirth
WASHINGTON (Feb. 13, 2017)—A study in the American Journal of Obstetrics & Gynecology finds that simple glucose supplementation reduces length of induced labor. The study (currently available online as an Article in Press, in advance of the May issue of the Journal), was initially presented two weeks ago at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting™. The study, “Reduction of total labor length through the addition of parenteral dextrose solution in induction of labor in nulliparous: results of DEXTRONS prospective randomized controlled trial,” was conducted by researchers with the Université de Sherbrooke in Sherbrooke, Quebec, Canada.
|Society for Mat...|
|02/10/2017 - 16:37||
Laser-based camera developed at UW improves view of the carotid artery to assess stroke and heart attack risk
Strokes and heart attacks often strike without warning. But a unique application of a medical camera developed by a University of Washington mechanical engineer could one day help physicians know who is at risk for a cardiovascular event by providing a better view of potential problem areas.
|02/10/2017 - 09:25||
Blue Cross & Blue Shield Of Rhode Island Pledges 80% By 2018: 80 Percent Of Adults 50 And Older Screened For Colorectal Cancer By 2018
Providence – Blue Cross & Blue Shield of Rhode Island (BCBSRI) has pledged to help increase colorectal cancer screening rates by supporting 80% by 2018, a National Colorectal Cancer Roundtable (NCCRT) initiative through which organizations nationwide have committed to substantially reducing colorectal cancer as a major public health problem by working toward the shared goal of 80% of adults aged 50 and older being regularly screened for colorectal cancer by 2018.
|Blue Cross Blue...|
|02/10/2017 - 09:12||
Alzheimers Research UK in record research investment with 24% rise in income
Alzheimer’s Research UK, the UK’s leading dementia research charity, has announced its biggest ever annual investment in research as its income for 2015-16 increased by nearly a quarter.
|02/10/2017 - 09:03||
UPMC Passavant Offers Free Non-Invasive Colon Cancer Screenings
WHAT: UPMC Cancer Center at UPMC Passavant will offer a non-invasive colon cancer screening program. The free screenings will include a FIT test kit (a more sensitive/easier stool test), bone density and blood pressure testing.
|02/10/2017 - 08:42||
Residents in Wales urged to live healthier lives to reduce dementia risk
Alzheimer’s Research UK, the UK’s leading dementia research charity, has welcomed a call to action to people in Wales, which is urging them to take positive steps to reduce their risk of dementia.
|02/10/2017 - 07:35||
Why Caring Matters Most
When Yale School of Nursing faculty member and philosopher Mark Lazenby, PhD, APRN, FAAN was asked to give a series of lectures on nursing and the good of society in the spring of 2013, his research into that intimidatingly broad subject led him to the very foundation of nursing itself…through the writing and work of YSN’s founding dean, Annie Goodrich.
|02/10/2017 - 07:25||
Department of Health Services Report Highlights Opioid Overdose and Death Rates in Wisconsin
The report provides statewide and county-level data on opioid-related deaths and hospital visits; neonatal abstinence syndrome (NAS), in which an infant is born with withdrawal symptoms from substances taken by the mother; and data on ambulance runs in which naloxone, a medication used to reverse opioid overdose, was administered.
|02/09/2017 - 16:45||
Three men indicted for heroin and cocaine conspiracy
Three men were indicted for their roles in a conspiracy to traffic heroin and cocaine, said Carole S. Rendon, U.S. Attorney for the Northern District of Ohio, and FBI Special Agent in Charge Stephen D. Anthony.
|02/09/2017 - 15:50||
Constant Challenge for Discovery Propels Harvinder Gill
The Texas Tech researcher has shown how vaccines can be administered more effectively through the use of creative methods of drug delivery.
|Texas Tech Univ...|
|02/09/2017 - 14:03||
FDA approves drug to treat Duchenne muscular dystrophy
The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system.
|02/09/2017 - 12:18||
Research study participation helps lower mans risk for diabetes
Elmo Winters has been participating in research studies at LSU's Pennington Biomedical Research Center for the past 17 years.
|02/09/2017 - 11:26||
When a heart stops working properly, time is of the essence
Anthony Tomassoni, MD, MS, offers tips for improving heart health and saving lives.
|02/09/2017 - 11:03||
Size matters when it comes to keeping blood sugar levels in check
Keeping blood sugar levels within a safe range is key to managing both type 1 and type 2 diabetes. In a new finding that could lead to fewer complications for diabetes patients, Yale School of Medicine researchers have found that changes in the size of mitochondria in a small subset of brain cells play a crucial role in safely maintaining blood sugar levels.
|02/09/2017 - 10:11||
Hair analysis may help diagnose Cushing Syndrome, NIH researchers report
Small study suggests that high cortisol level in hair may foretell hard-to-diagnose disorder.
|02/09/2017 - 09:26||
Yale scientists study how some insulin-producing cells survive in type 1 diabetes
A Yale-led research team identified how insulin-producing cells that are typically destroyed in type 1 diabetes can change in order to survive immune attack.
|02/09/2017 - 09:15||
Relationship Expert Teams Up with Pfizer to Address Intimacy and Relationship Issues for People Living with Chronic Diseases
People living with RA have a lot to cover and discuss during doctor visits.
|02/09/2017 - 05:20||
Recent Publication Highlights Proof-of-Concept Data Supporting the Diagnostic Potential of Phosphatidylserine-Positive Exosomes in Ovarian Cancer
TUSTIN, Calif., Feb. 09, 2017 ( ) -- Peregrine Pharmaceuticals, Inc.
|02/09/2017 - 05:20||
ABLYNX TO PRESENT ADDITIONAL DATA FOR ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, A POTENTIAL BEST-IN-CLASS TREATMENT FOR RHEUMATOID ARTHRITIS
Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] announced that today it will present additional data from the Phase IIb RA combination study of its anti-IL-6R Nanobody®, vobarilizumab, at the Annual Scientific Meeting of the Canadian Rheumatology Association, being held from 8-11 February 2017 in Ottawa, Ontario (Canada). These data will be presented in two posters which will be available on the Ablynx website shortly after the conference.
|02/08/2017 - 16:11||
Heart Disease Still Tennessee's Top Cause of Death
NASHVILLE – While matters of the heart are top of mind near Valentine’s Day, more Tennesseans should think about them all year long to ensure healthier, longer lives. Tennessee Department of Health data show heart disease is still the leading cause of death in the state, while stroke rated fifth in claiming lives.